TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35285674

Group type: EXPERIMENTAL
Intervention: Balance It
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bubble Pop
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scoop'd
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study: 32822218

Group type: EXPERIMENTAL
Intervention: Moderate workload condition (level 3)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lead time of 7 seconds
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lower workload conditions (level 1 and level 2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Higher workload condition (level 4)
Number of subjects: 50
Study: 32944800

Group type: EXPERIMENTAL
Intervention: Lipegfilgrastim
Number of subjects: 101

Group type: COMPARATOR
Intervention: Pegfilgrastim
Number of subjects: 101
Study: 32409830

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Surgery plus adjuvant chemotherapy (standard treatment)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy
Number of subjects: 110
Study: 34619066

Group type: EXPERIMENTAL
Intervention: Supportive text messages
Number of subjects: 324

Group type: COMPARATOR
Intervention: Control group (no text messages)
Number of subjects: 324
Study: 34697252

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise (EXE)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: EXE + RAD
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (exposure to an experimental phone without battery)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: RAD (exposure to 900/1800 MHz radiofrequency electromagnetic waves 3 hours per day)
Number of subjects: 32
Study: 34810344

Group type: EXPERIMENTAL
Intervention: Probiotic curd
Number of subjects: 40

Group type: COMPARATOR
Intervention: Synbiotic curd
Number of subjects: 40
Study: 35092599

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group (routine education and support)
Number of subjects: 184
Study: 33293394

Group type: EXPERIMENTAL
Intervention: No antenatal care (ANC) visit
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: No postnatal care (PNC) visit
Number of subjects: 603
Study: 35270204

Group type: EXPERIMENTAL
Intervention: Strengths and Empowerment (RISE)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Enhanced Care as Usual (ECAU)
Number of subjects: 58
Study: 34810385

Group type: EXPERIMENTAL
Intervention: Flexible Spiral Wire (FSW)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ceramic Interlocking Retainer
Number of subjects: 40
Study: 32470239

Group type: EXPERIMENTAL
Intervention: PBM followed by the application of nHAP (GLasernHAP)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Simulated PBM followed by the application of nHAP (GnHAP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Simulated PBM followed by nHAP-free toothpaste (GPlacebo)
Number of subjects: 32

Group type: COMPARATOR
Intervention: PBM followed by nHAP-free toothpaste (GLaser)
Number of subjects: 32
Study: 34352146

Group type: EXPERIMENTAL
Intervention: MFU‐V combined with L‐HA injection (combined technique)
Number of subjects: 46

Group type: COMPARATOR
Intervention: MFU‐V monotherapy (single technique)
Number of subjects: 46
Study: 32542370

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (200 mg Venofer® in 100 ml saline on days 1, 3, and 5)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo (100 ml saline)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 33208325

Group type: EXPERIMENTAL
Intervention: Zinc biofortified wheat flour (target zinc concentration of 40 mg/kg)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Locally procured wheat flour from standard varieties (expected zinc concentration of 20 mg/kg)
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Zinc biofortified wheat flour
Number of subjects: 482

Group type: COMPARATOR
Intervention: Locally procured wheat flour from standard varieties
Number of subjects: 482
Study: 36223203

Group type: EXPERIMENTAL
Intervention: K9 springs
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ballista springs
Number of subjects: 30
Study: 33648568

Group type: EXPERIMENTAL
Intervention: Dexamethasone 20 mg intravenously once daily on days 1-5, followed by 10 mg on days 6-10
Number of subjects: 300

Group type: COMPARATOR
Intervention: Dexamethasone 6 mg intravenously once daily on days 1-10
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Dexamethasone 20 mg
Number of subjects: 300
Study: 35487723

Group type: EXPERIMENTAL
Intervention: Genetics Adviser + brief genetic counselling session
Number of subjects: 140

Group type: COMPARATOR
Intervention: Genetic counselling alone
Number of subjects: 140
Study: 34021043

Group type: EXPERIMENTAL
Intervention: Closed-loop neurofeedback (cNF) training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Closed-loop neurofeedback (cNF) training in children with ADHD
Number of subjects: 0
Study: 35171122

Group type: EXPERIMENTAL
Intervention: DoCTRINE checklist (intervention group)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no checklist)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Overall interrater agreement
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Accepted vs rejected submissions
Number of subjects: 108
Study: 34162769

Group type: EXPERIMENTAL
Intervention: One-step knife (OSK)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional knife (CK)
Number of subjects: 51
Study: 35462372

Group type: EXPERIMENTAL
Intervention: Desidustat 100 mg oral tablets thrice a week for 24 weeks
Number of subjects: 588

Group type: COMPARATOR
Intervention: Biosimilar darbepoetin subcutaneous injection 0.75 μg/kg once in 2 weeks for 24 weeks
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Desidustat
Number of subjects: 588

Group type: COMPARATOR
Intervention: Darbepoetin
Number of subjects: 588
Study: 34217249

Group type: EXPERIMENTAL
Intervention: Neo-adjuvant radiotherapy (NRT)
Number of subjects: 5272

Group type: COMPARATOR
Intervention: Non-neo-adjuvant radiotherapy (non-NRT)
Number of subjects: 5272
Study: 33984220

Group type: EXPERIMENTAL
Intervention: Upper-body forced-air blanket
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lower-body forced-air blanket
Number of subjects: 120
Study: 35177442

Group type: EXPERIMENTAL
Intervention: Supplementary feeding for MAM infants
Number of subjects: 198
Study: 33449843

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 39

Group type: COMPARATOR
Intervention: Fractional Er:YAG laser
Number of subjects: 39
Study: 32320405

Group type: EXPERIMENTAL
Intervention: DREAMS Partnership
Number of subjects: 1687
Study: 36440678

Group type: EXPERIMENTAL
Intervention: Education program (7-hours self-directed learning; 3-hour online workshop)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 49
Study: 35877056

Group type: EXPERIMENTAL
Intervention: Mentoring from Big Brothers Big Sisters of America (BBBS) affiliates
Number of subjects: 188

Group type: COMPARATOR
Intervention: Non-compliers (adolescents in the intervention group who did not receive a mentor)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 188
Study: 33580472

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids treatment for 16 weeks
Number of subjects: 40
Study: 35229668

Group type: EXPERIMENTAL
Intervention: Ofatumumab
Number of subjects: 1969

Group type: COMPARATOR
Intervention: Teriflunomide (newly switched)
Number of subjects: 1969
Study: 36447623

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (VR) therapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Standard neurological rehabilitation + VR therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Schultz's Autogenic Training (SAT)
Number of subjects: 60
Study: 33558352

Group type: EXPERIMENTAL
Intervention: Tai chi exercise intervention for 24 weeks
Number of subjects: 106

Group type: COMPARATOR
Intervention: Health education control for 24 weeks
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: fMRI and P300 measurements at baseline and 24 weeks
Number of subjects: 106
Study: 36170320

Group type: EXPERIMENTAL
Intervention: Modified conventional drilling technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional drilling technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Simplified drilling technique
Number of subjects: 30
Study: 34916467

Group type: EXPERIMENTAL
Intervention: 600 mg rifampin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 900 mg rifampin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1200 mg rifampin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All doses of rifampin
Number of subjects: 10
Study: 35973185

Group type: EXPERIMENTAL
Intervention: High total / low simple carbohydrate diet (HTLS)
Number of subjects: 98

Group type: COMPARATOR
Intervention: High total / high simple carbohydrate diet (HTHS)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: All carbohydrate modification groups
Number of subjects: 98
Study: 34551948

Group type: COMPARATOR
Intervention: Standard pulmonary rehabilitation (PR) with sham inspiratory muscle training (IMT)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Standard pulmonary rehabilitation (PR) added to inspiratory muscle training (IMT)
Number of subjects: 138
Study: 34032304

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32951460

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cause-specific survival (CSS) probabilities for TSCC patients.
Number of subjects: 7243

Group type: EXPERIMENTAL
Intervention: Calibration plots and decision-curve analysis (DCA) for the nomogram.
Number of subjects: 7243
Study: 32749625

Group type: EXPERIMENTAL
Intervention: Web-based cognitive training program
Number of subjects: 58

Group type: COMPARATOR
Intervention: Attention control training
Number of subjects: 58
Study: 34154470

Group type: EXPERIMENTAL
Intervention: Parenting training (6 sessions of 120 minutes each) in addition to routine clinical care
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine clinical care
Number of subjects: 80
Study: 34004161

Group type: EXPERIMENTAL
Intervention: Plasma and SAAT-derived exosomes from OB-NAFLD group
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Proinflammatory macrophages and CD4/CD8 T-cell populations in SAAT
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Plasma PAI-1 concentrations
Number of subjects: 70

Group type: COMPARATOR
Intervention: 24-hour plasma cytokine concentration areas-under-the-curve
Number of subjects: 70

Group type: COMPARATOR
Intervention: Percentage of proinflammatory macrophages and plasma PAI-1 concentration areas-under-the-curve
Number of subjects: 70
Study: 36412403

Group type: EXPERIMENTAL
Intervention: Gemcitabine (150 mg/m2 weekly)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cisplatin (35 mg/m2 weekly)
Number of subjects: 60
Study: 33590475

Group type: EXPERIMENTAL
Intervention: Motivational Interview‐Enhanced Safety Plan (MI‐SP) + Texts
Number of subjects: 80

Group type: COMPARATOR
Intervention: MI‐SP + Texts
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Booster calls
Number of subjects: 80

Group type: COMPARATOR
Intervention: MI‐SP alone
Number of subjects: 80
Study: 35248721

Group type: EXPERIMENTAL
Intervention: Prebiotics
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32993388

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Current pharmacological treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emerging pharmacological treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapies
Number of subjects: 0
Study: 34263511

Group type: EXPERIMENTAL
Intervention: People living with HIV (PLWH)
Number of subjects: 14134

Group type: COMPARATOR
Intervention: Uninfected controls
Number of subjects: 14134
Study: 32832225

Group type: EXPERIMENTAL
Intervention: MI-OCT feedback (group B)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No MI-OCT feedback (group A)
Number of subjects: 24
Study: 36102267

Group type: EXPERIMENTAL
Intervention: Bilateral asymmetric lateral rectus recession
Number of subjects: 80

Group type: COMPARATOR
Intervention: Unilateral lateral rectus recession and medial rectus resection
Number of subjects: 80
Study: 33956945

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infections screening
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: IgG seroreactivity assessment
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Common cold-resembling symptoms assessment
Number of subjects: 720
Study: 32416022

Group type: EXPERIMENTAL
Intervention: High-risk chief complaints (CCs)
Number of subjects: 21953

Group type: EXPERIMENTAL
Intervention: Low-risk chief complaints (CCs)
Number of subjects: 21953
Study: 35550261

Group type: EXPERIMENTAL
Intervention: BNT162b2 (30 μg in 0.30 mL; full dose)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: mRNA-1273 (50 μg in 0.25 mL; half dose)
Number of subjects: 166
Study: 34886071

Group type: EXPERIMENTAL
Intervention: Exposure to tweets about harms of e-cigarettes (various levels of misinformation)
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Exposure to tweets about harms of e-cigarettes
Number of subjects: 2400
Study: 34996427

Group type: EXPERIMENTAL
Intervention: Modified Bakay technique (MT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard colpotomy (ST)
Number of subjects: 160
Study: 34838094

Group type: COMPARATOR
Intervention: Assessment interviews (part of the control group)
Number of subjects: 15
Study: 32814500

Group type: EXPERIMENTAL
Intervention: QR code-based video education program accessed multiple times on smartphones
Number of subjects: 335

Group type: COMPARATOR
Intervention: Control group watched the same video on a tablet once
Number of subjects: 335
Study: 35487299

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg/day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 33370370

Group type: EXPERIMENTAL
Intervention: Experiential learning program after dementia supporter training
Number of subjects: 81

Group type: COMPARATOR
Intervention: Dementia supporter training only (control group)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Experiential learning program
Number of subjects: 81
Study: 35061999

Group type: EXPERIMENTAL
Intervention: Trainer in residence professional development program
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Postprogram observations
Number of subjects: 139
Study: 33831942

Group type: EXPERIMENTAL
Intervention: Bladder instillation with triamcinolone acetonide
Number of subjects: 90

Group type: COMPARATOR
Intervention: Bladder instillation without triamcinolone acetonide
Number of subjects: 90
Study: 35076639

Group type: EXPERIMENTAL
Intervention: Cognitive training (hour-long dual N-back and attention network tasks, 5 days per week for 4 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no cognitive training)
Number of subjects: 29
Study: 33617863

Group type: COMPARATOR
Intervention: motion-sensing, hands-free gaming device plus traditional rehabilitation (TR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: task-oriented training (TOT) plus traditional rehabilitation (TR)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: traditional rehabilitation (TR)
Number of subjects: 50
Study: 616120592

Group type: EXPERIMENTAL
Intervention: EBI‐005 (5 or 20 mg/mL)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 74
Study: 35298522

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Hot pack treatment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control
Number of subjects: 64
Study: 32416201

Group type: EXPERIMENTAL
Intervention: Exercise-based cardiac rehabilitation (CR+)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Control group (CR-)
Number of subjects: 524
Study: 34792290

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) sessions (n = 67)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard information only (Control group, n = 68)
Number of subjects: 135
Study: 33227224

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) applied over 14 sites per lower limb immediately before 1500 m run, delivering 30 J per site, total energy dose of 840 J.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 34643888

Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (PRO group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (CON group)
Number of subjects: 200
Study: 34496859

Group type: EXPERIMENTAL
Intervention: Multi-component intervention (self-monitoring of steps with counselling support)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Single-component intervention (self-monitoring of steps without counselling support)
Number of subjects: 188
Study: 34791771

Group type: EXPERIMENTAL
Intervention: Multi-plant extracts product (oral intake for 12 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: UV+high dose group (0.500 g/kg.BW)
Number of subjects: 55

Group type: COMPARATOR
Intervention: UV+moderate dose group (0.250 g/kg.BW)
Number of subjects: 55

Group type: COMPARATOR
Intervention: UV+low dose group (0.125 g/kg.BW)
Number of subjects: 55

Group type: COMPARATOR
Intervention: UV+high and moderate dose groups
Number of subjects: 55
Study: 34144852

Group type: EXPERIMENTAL
Intervention: HPV vaccination program in schools
Number of subjects: 221
Study: 32508043

Group type: EXPERIMENTAL
Intervention: Video educational tool
Number of subjects: 150

Group type: COMPARATOR
Intervention: Verbal description of hospice
Number of subjects: 150
Study: 33766074

Group type: EXPERIMENTAL
Intervention: Tofacitinib (detailed dosage not specified)
Number of subjects: 816
Study: 33780928

Group type: EXPERIMENTAL
Intervention: 200 mL of water every 2 hours (1,600 mL per day)
Number of subjects: 92

Group type: COMPARATOR
Intervention: 100 mL of water every 2 hours (800 mL per day)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 110 mL of water every 1 hour (1,650 mL per day)
Number of subjects: 92
Study: 34000987

Group type: EXPERIMENTAL
Intervention: Lighted stylet bent at 70 degrees
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lighted stylet bent at 80 degrees
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lighted stylet bent at 90 degrees
Number of subjects: 0
Study: 32819928

Group type: EXPERIMENTAL
Intervention: ENACT (Environmental enrichment for infants; parenting with Acceptance and Commitment Therapy)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 66
Study: 34873117

Group type: EXPERIMENTAL
Intervention: Physical therapy protocol based on physical exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hospital's physical therapy protocol
Number of subjects: 20
Study: 32706812

Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention (LI)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Health and Wellness (HW)
Number of subjects: 204
Study: 35777155

Group type: EXPERIMENTAL
Intervention: 5% Almond Shell-based Biochar (ASB)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Almond Shell (AS) and Almond Shell-based Biochar (ASB) in different mass ratios (5%, 10%, 15%)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control (no amendment)
Number of subjects: 3
Study: 33412262

Group type: EXPERIMENTAL
Intervention: 10-fraction SBRT (48.5 Gy in 10 fractions)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 5-fraction SBRT (35 Gy in 5 fractions)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both 10-fraction and 5-fraction SBRT
Number of subjects: 57
Study: 32312838

Group type: EXPERIMENTAL
Intervention: CRISPR/Cas9 mediated activation of gene expression to select for loss-of-function alleles
Number of subjects: 45000
Study: 35582999

Group type: COMPARATOR
Intervention: Mometasone nasal spray for four weeks (M)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mometasone nasal spray plus oral commercially available quail egg and zinc tablets (M+N)
Number of subjects: 40
Study: 34453268

Group type: EXPERIMENTAL
Intervention: Community service-linkage model to evidence-based programs (targeted provider outreach)
Number of subjects: 4873

Group type: COMPARATOR
Intervention: Treatment-as-usual (control group)
Number of subjects: 4873
Study: 32503041

Group type: EXPERIMENTAL
Intervention: Addition of cooking ash
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Addition of boiling water
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neither intervention (control group)
Number of subjects: 0
Study: 616463931

Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 0
Study: 35318738

Group type: EXPERIMENTAL
Intervention: 4 g rosemary leaf powder
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (starch) powders
Number of subjects: 110
Study: 34920968

Group type: EXPERIMENTAL
Intervention: H2GO! intervention (usual BGC programming plus H2GO!)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual BGC programming (control group)
Number of subjects: 100
Study: 32379496

Group type: EXPERIMENTAL
Intervention: Type 1 Doing Well app
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual medical care (control)
Number of subjects: 80
Study: 35559526

Group type: EXPERIMENTAL
Intervention: Critical reflection blended with technology (Group C)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Video recording of role-play (Group B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional practical demonstration (Group A)
Number of subjects: 150
Study: 34186281

Group type: EXPERIMENTAL
Intervention: O3-AHT (Ozone autohemotherapy)
Number of subjects: 92

Group type: COMPARATOR
Intervention: SoC (Standard of Care)
Number of subjects: 92
Study: 35026491

Group type: EXPERIMENTAL
Intervention: iCanQuit
Number of subjects: 897

Group type: COMPARATOR
Intervention: QuitGuide
Number of subjects: 897